Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NASDAQ:ONVO)

2.76
Delayed Data
As of Jun 23
 +0.05 / +1.85%
Today’s Change
2.48
Today|||52-Week Range
4.99
-18.58%
Year-to-Date
Biotech Movers: Shire, Bellicum, Organovo
Jun 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close2.71
Today’s open2.71
Day’s range2.68 - 2.77
Volume1,307,002
Average volume (3 months)1,002,058
Market cap$288.7M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+9.30%
Earnings growth (this year)-0.64%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+185.23%
P/E ratioNM
Price/Sales73.50
Price/Book4.63

Competitors

 Today’s
change
Today’s
% change
VYGRVoyager Therapeutics...+0.11+1.07%
TOCATocagen Inc-0.64-4.39%
CRISCuris Inc-0.01-0.47%
EDGEEdge Therapeutics In...-0.37-3.60%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$4.2M
Annual profit (last year)-$38.4M
Net profit margin-908.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Taylor J. Crouch
Chief Financial &
Accounting Officer
Craig S. Kussman
Corporate headquarters
San Diego, California

Forecasts